APA Zitierstil

OKITA, R., SHIMIZU, K., NOJIMA, Y., YUKAWA, T., MAEDA, A., SAISHO, S., & NAKATA, M. (2015). Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells. Oncol Rep.

Chicago Zitierstil

OKITA, RIKI, KATSUHIKO SHIMIZU, YUJI NOJIMA, TAKURO YUKAWA, AI MAEDA, SHINSUKE SAISHO, und MASAO NAKATA. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.

MLA Zitierstil

OKITA, RIKI, et al. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.